MainReads
← Details
Efficacy and safety of niraparib as maintenance treatment in older patients (≥ 70 years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trial
Michel Fabbro, Kathleen N. Moore, Anne Dørum, Anna V. Tinker, Sven Mahner, Isabel Bover, Susana Banerjee, Germana Tognon, Frederic Goffin, Ronnie Shapira-Frommer, Robert M. Wenham, Kristina Hellman, Diane Provencher, Philipp Harter, Isabel Palacio Vázquez, Philippe Follana, Mario J. Pineda, Mansoor R. Mirza, Sebastien J. Hazard, Ursula A. Matulonis
/
-
Loading document from repository...
Unable to Display Document
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.